These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1451234)

  • 1. Nitric oxide: its production in host-cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.
    Thomsen LL; Baguley BC; Wilson WR
    Cancer Chemother Pharmacol; 1992; 31(2):151-5. PubMed ID: 1451234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin involvement in the antitumour and host effects of flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.
    Baguley BC; Cole G; Thomsen LL; Li Z
    Cancer Chemother Pharmacol; 1993; 33(1):77-81. PubMed ID: 8269593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of tumor necrosis factor-alpha messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488).
    Ching LM; Joseph WR; Crosier KE; Baguley BC
    Cancer Res; 1994 Feb; 54(4):870-2. PubMed ID: 8313372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid.
    Laws AL; Matthew AM; Double JA; Bibby MC
    Br J Cancer; 1995 Jun; 71(6):1204-9. PubMed ID: 7779712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents flavone-8-acetic acid and xanthenone-4-acetic acid.
    Thomsen LL; Ching LM; Baguley BC
    Cancer Res; 1990 Nov; 50(21):6966-70. PubMed ID: 2170013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent induction of nitric oxide synthase in tumours from mice treated with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid.
    Moilanen E; Thomsen LL; Miles DW; Happerfield DW; Knowles RG; Moncada S
    Br J Cancer; 1998; 77(3):426-33. PubMed ID: 9472639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma pharmacokinetics of the antitumour agents 5,6-dimethylxanthenone-4-acetic acid, xanthenone-4-acetic acid and flavone-8-acetic acid in mice.
    McKeage MJ; Kestell P; Denny WA; Baguley BC
    Cancer Chemother Pharmacol; 1991; 28(6):409-13. PubMed ID: 1934244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of 5,6-dimethylxanthenone-4-acetic acid on tumour necrosis factor production by human immune cells.
    Patel S; Parkin SM; Bibby MC
    Anticancer Res; 1997; 17(1A):141-50. PubMed ID: 9066644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavone acetic acid and 5,6-dimethylxanthenone-4-acetic acid: relationship between plasma nitrate elevation and the induction of tumour necrosis.
    Veszelovszky E; Thomsen LL; Li Z; Baguley BC
    Eur J Cancer; 1993; 29A(3):404-8. PubMed ID: 8398341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid.
    Ching LM; Xu ZF; Gummer BH; Palmer BD; Joseph WR; Baguley BC
    Br J Cancer; 1995 Aug; 72(2):339-43. PubMed ID: 7640215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of immune effector cells in flavone acetic acid-induced injury to tumor cells in EMT6 spheroids.
    Zwi LJ; Baguley BC; Gavin JB; Holdaway KM; Wilson WR
    Oncol Res; 1992; 4(8-9):333-9. PubMed ID: 1486217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of macrophage tumouricidal activity by 5,6-dimethyl-xanthenone-4-acetic acid, a potent analogue of the antitumour agent flavone-8-acetic acid.
    Ching LM; Joseph WR; Baguley BC
    Biochem Pharmacol; 1992 Jul; 44(1):192-5. PubMed ID: 1632835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-dependent increased plasma nitrate concentrations as an indication of the antitumor effect of flavone-8-acetic acid and analogues in mice.
    Thomsen LL; Ching LM; Zhuang L; Gavin JB; Baguley BC
    Cancer Res; 1991 Jan; 51(1):77-81. PubMed ID: 1988109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ability of coumarin-, flavanon- and flavonol-analogues of flavone acetic acid to stimulate human monocytes.
    Barbera M; Caputo A; Zampiron A; Gobbi S; Rampa A; Bisi A; Carrara M
    Oncol Rep; 2008 Jan; 19(1):187-96. PubMed ID: 18097594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in coagulation and permeability properties of human endothelial cells in vitro induced by TNF-alpha or 5,6 MeXAA.
    Watts ME; Arnold S; Chaplin DJ
    Br J Cancer Suppl; 1996 Jul; 27():S164-7. PubMed ID: 8763872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide production in endotoxin-resistant C3H/HeJ mice stimulated with flavone-8-acetic acid and xanthenone-4-acetic acid analogues.
    Thomsen LL; Ching LM; Joseph WR; Baguley BC; Gavin JB
    Biochem Pharmacol; 1992 Jun; 43(11):2401-6. PubMed ID: 1610403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of STAT and NFkappaB activation by the antitumor agents 5,6-dimethylxanthenone-4-acetic acid and flavone acetic acid in a murine macrophage cell line.
    Ching LM; Young HA; Eberly K; Yu CR
    Biochem Pharmacol; 1999 Oct; 58(7):1173-81. PubMed ID: 10484075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of DT-diaphorase (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA): implications for bioreductive drug development.
    Phillips RM
    Biochem Pharmacol; 1999 Jul; 58(2):303-10. PubMed ID: 10423172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of LPS-inducible genes by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid in primary murine macrophages. Dissection of signaling pathways leading to gene induction and tyrosine phosphorylation.
    Perera PY; Barber SA; Ching LM; Vogel SN
    J Immunol; 1994 Nov; 153(10):4684-93. PubMed ID: 7525711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid.
    Browne WL; Wilson WR; Baguley BC; Ching LM
    Anticancer Res; 1998; 18(6A):4409-13. PubMed ID: 9891501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.